Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13DFiled 5 days ago

Nexalin Technology, Inc.: Greenlight Ventures, LLC amends Schedule 13D stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13D, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13D

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Greenlight Ventures, LLC amended its Schedule 13D stake filing for Nexalin Technology, Inc., disclosing the change to the SEC under accession number 0001829126-26-012395. The filing signals a shift in the investor's position in the medical device maker, though the amended document did not specify the revised ownership percentage in the headline disclosure. Schedule 13D amendments are typically watched for changes in activist intent or ownership thresholds that can influence corporate strategy. Investors will look to the full filing for details on Greenlight's current stake size and any stated plans regarding Nexalin's board or operations.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.

Named in this story

Greenlight Ventures, LLC, Nexalin Technology, Inc.